Improving T-cell responses against tumors by fixing RNA splicing issues
Unleashing T-cell anti-tumor response through repair of altered RNA splicing and antigen mimicry recognition
This study is looking for ways to help your immune system better fight tough cancers by improving how it recognizes and attacks tumor cells, with the goal of creating new treatments and vaccines that work better for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10472211 on NIH RePORTER |
What this research studies
This research investigates how to enhance the immune system's ability to fight solid tumors by addressing problems with RNA splicing and T-cell recognition of cancer cells. The approach focuses on understanding the mechanisms that influence T-cell activity and developing new immunotherapies and cancer vaccines that can effectively target tumors. By exploring unconventional methods to boost anti-tumor immunity, the research aims to create treatments that are more effective for patients with aggressive cancers.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with aggressive solid tumors who have not responded well to current immunotherapy treatments.
Not a fit: Patients with non-solid tumors or those who have already had successful responses to existing immunotherapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective immunotherapies and cancer vaccines that significantly improve patient outcomes in solid tumors.
How similar studies have performed: While there have been advancements in immunotherapy, this research explores novel mechanisms that have not been extensively tested, making it a potentially groundbreaking approach.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Escobar Hoyos, Luisa — Yale University
- Study coordinator: Escobar Hoyos, Luisa
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.